Quieter cravings
Create more space between you and food noise
Think about food less. Feel more in control.
When cravings and constant thoughts about food take up too much space, semaglutide may help make eating feel calmer and progress feel more manageable. It is a well-studied, once-weekly GLP-1 option designed to work alongside the habits you are already building.

Create more space between you and food noise
Feel more intentional around meals
Keep treatment simple with a weekly routine
People who want a familiar, well-studied way to quiet cravings and support steady weight loss.
The established GLP-1 path: one metabolic pathway, one weekly routine, and gradual adjustments based on how you feel.
In the STEP 1 trial, adults without diabetes received once-weekly semaglutide 2.4 mg or placebo alongside lifestyle intervention for 68 weeks.
STEP 1 (N=1,961). Semaglutide 2.4 mg trial results do not establish expected results for a compounded product. Individual results vary. Wilding JPH et al. N Engl J Med. 2021;384:989–1002.
This drug is compounded by a licensed pharmacy in accordance with Section 503A of the Federal Food, Drug & Cosmetic Act and may be dispensed only under a patient-specific prescription issued by a licensed practitioner following a medical evaluation. FDA does not review or approve compounded medications for safety, effectiveness, or quality. Individual results may vary. This compounded formulation is not affiliated with, endorsed or approved by, or intended to replace products manufactured by Novo Nordisk. Actual product packaging may differ from images shown.